These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

133 related items for PubMed ID: 32298666

  • 1. The mechanism of lncRNA H19 in fibrosis and its potential as novel therapeutic target.
    Jiang X, Ning Q.
    Mech Ageing Dev; 2020 Jun; 188():111243. PubMed ID: 32298666
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. The mechanisms and therapeutic potential of long noncoding RNA NEAT1 in fibrosis.
    Jiang X.
    Clin Exp Med; 2023 Nov; 23(7):3339-3347. PubMed ID: 37740135
    [Abstract] [Full Text] [Related]

  • 4. Circular RNAs as novel regulators, biomarkers and potential therapies in fibrosis.
    Jiang X, Ning Q.
    Epigenomics; 2019 Jul; 11(9):1107-1116. PubMed ID: 31240943
    [Abstract] [Full Text] [Related]

  • 5. Long Noncoding RNA H19 Acts as a Competing Endogenous RNA to Mediate CTGF Expression by Sponging miR-455 in Cardiac Fibrosis.
    Huang ZW, Tian LH, Yang B, Guo RM.
    DNA Cell Biol; 2017 Sep; 36(9):759-766. PubMed ID: 28753062
    [Abstract] [Full Text] [Related]

  • 6. Analysis of the Paternally-Imprinted DLK1-MEG3 and IGF2-H19 Tandem Gene Loci in NT2 Embryonal Carcinoma Cells Identifies DLK1 as a Potential Therapeutic Target.
    Sellers ZP, Schneider G, Maj M, Ratajczak MZ.
    Stem Cell Rev Rep; 2018 Dec; 14(6):823-836. PubMed ID: 29980981
    [Abstract] [Full Text] [Related]

  • 7. Long noncoding RNA: a new contributor and potential therapeutic target in fibrosis.
    Jiang X, Zhang F.
    Epigenomics; 2017 Sep; 9(9):1233-1241. PubMed ID: 28809130
    [Abstract] [Full Text] [Related]

  • 8. Long noncoding RNA H19 controls DUSP5/ERK1/2 axis in cardiac fibroblast proliferation and fibrosis.
    Tao H, Cao W, Yang JJ, Shi KH, Zhou X, Liu LP, Li J.
    Cardiovasc Pathol; 2016 Sep; 25(5):381-9. PubMed ID: 27318893
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Knockdown of Long Noncoding RNA H19 Represses the Progress of Pulmonary Fibrosis through the Transforming Growth Factor β/Smad3 Pathway by Regulating MicroRNA 140.
    Wang X, Cheng Z, Dai L, Jiang T, Jia L, Jing X, An L, Wang H, Liu M.
    Mol Cell Biol; 2019 Jun 15; 39(12):. PubMed ID: 30988156
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. LncRNA: Shedding light on mechanisms and opportunities in fibrosis and aging.
    Yang Z, Jiang S, Shang J, Jiang Y, Dai Y, Xu B, Yu Y, Liang Z, Yang Y.
    Ageing Res Rev; 2019 Jul 15; 52():17-31. PubMed ID: 30954650
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Dysregulation of lncRNA-H19 in cardiometabolic diseases and the molecular mechanism involved : a systematic review.
    Hernández-Aguilar AI, Luciano-Villa CA, Tello-Flores VA, Beltrán-Anaya FO, Zubillaga-Guerrero MI, Flores-Alfaro E.
    Expert Rev Mol Diagn; 2021 Aug 15; 21(8):809-821. PubMed ID: 34133256
    [Abstract] [Full Text] [Related]

  • 18. The imprinted H19 noncoding RNA is a primary microRNA precursor.
    Cai X, Cullen BR.
    RNA; 2007 Mar 15; 13(3):313-6. PubMed ID: 17237358
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.